You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vaccine booster

Showing 1 - 25 of 8,701
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chikungunya Virus Infection Trial (PXVX0317 vaccine booster, Placebo booster)

Not yet recruiting
  • Chikungunya Virus Infection
  • PXVX0317 vaccine booster
  • Placebo booster
  • (no location specified)
Aug 18, 2023

COVID-19 Trial in Nanjing (Intramuscularly administered Ad5-nCoV vaccine, Aerosolized Ad5-nCoV, DelNS1-2019-nCoV-RBD-OPT1)

Not yet recruiting
  • COVID-19
  • Intramuscularly administered Ad5-nCoV vaccine
  • +3 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
May 10, 2023

COVID-19 Pandemic, Immunogenicity, SARS CoV 2 Infection Trial in Ramat-Gan (mRNA-1273.214 Vaccine, MRNA-1273 Vaccine, Placebo)

Recruiting
  • COVID-19 Pandemic
  • +3 more
  • mRNA-1273.214 Vaccine
  • +2 more
  • Ramat-Gan, Israel
    Sheba Medical Center
Oct 26, 2022

Rheumatoid Arthritis, Autoimmune Rheumatologic Disease, Systemic Lupus Erythematosus Trial in Québec (COVID-19 vaccine)

Recruiting
  • Rheumatoid Arthritis
  • +8 more
  • COVID-19 vaccine
  • Montréal, Quebec, Canada
  • +1 more
Jan 13, 2023

COVID-19 Trial in United States (XBB.1.5 Vaccine (Booster), XBB.1.5 Vaccine (single dose))

Not yet recruiting
  • COVID-19
  • XBB.1.5 Vaccine (Booster)
  • XBB.1.5 Vaccine (single dose)
  • Mobile, Alabama
  • +29 more
Aug 4, 2023

COVID-19 Trial (GLB-COV2-043, BNT162b2/COMIRNATY®)

Not yet recruiting
  • COVID-19
  • (no location specified)
Oct 31, 2022

COVID-19 Trial in Tübingen, Hamburg (Prime-2-CoV_Beta)

Recruiting
  • COVID-19
  • Prime-2-CoV_Beta
  • Tübingen, Baden-Württemberg, Germany
  • +1 more
Jul 13, 2022

COVID-19 Trial in Shanghai, Beijing (Vaccine, COVID19)

Active, not recruiting
  • COVID-19
  • Vaccine, COVID19
  • Shanghai, Jingan, China
  • +1 more
Feb 12, 2022

Chronic Lymphocytic Leukemia, COVID-19 Infection Trial in Duarte (Biospecimen Collection, mRNA COVID-19 Vaccine, Synthetic

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • COVID-19 Infection
  • Biospecimen Collection
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Yellow Fever Trial (17D Yellow fever vaccine)

Not yet recruiting
  • Yellow Fever
  • 17D Yellow fever vaccine
  • (no location specified)
Apr 11, 2022

Multiple Myeloma, AL Amyloidosis, Chronic Lymphocytic Leukemia Trial in Detroit (A single "booster" dose of the Moderna mRNA

Recruiting
  • Multiple Myeloma
  • +2 more
  • A single "booster" dose of the Moderna mRNA COVID-19 vaccine
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
Apr 12, 2022

Moderna COVID-19 Bivalent Booster for Omicron BA.4/5

Recruiting
  • COVID-19
  • Moderna COVID-19 Vaccine
  • +3 more
  • Culver City, California
    Science37
Mar 9, 2023

COVID-19 Trial in Guangzhou (the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine)

Recruiting
  • COVID-19
  • the recombinant SARS-CoV-2 S-Trimer vaccine/inactivated SARS-CoV-2 vaccine
  • Guangzhou, Guangzhou, China
    The Fifth Affiliated Hospital of Guangzhou Medical University
Jan 28, 2023

COVID-19 Trial (SARS-CoV-2 Subunit Recombinant Protein Vaccine)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Subunit Recombinant Protein Vaccine
  • (no location specified)
Jul 5, 2023

COVID-19 Trial (1 Nebulized inhalation for booster groups, 2 Nebulized inhalation for booster groups, 3 Nebulized inhalation for

Recruiting
  • COVID-19
  • 1 Nebulized inhalation for booster groups
  • +23 more
  • Xiangxi, Hunan, China
    CDC of of Luxi County, Xiangxi Tujia and Miao Autonomous Prefect
Oct 24, 2022

Humoral Immunity Trial in Gomel (Protein subunit vaccine Soberana Plus (FINLAY-FR-1A) is a vaccine against COVID-19 produced by

Enrolling by invitation
  • Humoral Immunity
  • Protein subunit vaccine Soberana Plus (FINLAY-FR-1A) is a vaccine against COVID-19 produced by The Finlay Vaccine Institute and The Centre of Molecular Immunology (Republic of Cuba)
  • Gomel, Belarus
    Gomel State Medical University
Jan 30, 2023

Dengue Fever, Dengue Hemorrhagic Fever Trial in Singapore (CYD Dengue Vaccine (5 dose formulation), Placebo, NaCl 0.9%)

Completed
Has Results
  • Dengue Fever
  • Dengue Hemorrhagic Fever
  • CYD Dengue Vaccine (5 dose formulation)
  • Placebo, NaCl 0.9%
  • Singapore, Singapore
  • +2 more
Mar 15, 2022

COVID-19 Trial in Natal, São Paulo (SCB-2019/Clover, AstraZeneca/Fiocruz, Pfizer/Wyeth)

Active, not recruiting
  • COVID-19
  • SCB-2019/Clover
  • +2 more
  • Natal, Rio Grande Do Norte, Brazil
  • +1 more
Apr 10, 2023

COVID-19 Trial (Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C), Recombinant COVID-19

Not yet recruiting
  • COVID-19
  • Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C)
  • Recombinant COVID-19 vaccine(Sf9 Cell) (WSK-V101)
  • (no location specified)
Jun 19, 2023

COVID-19 Trial in Manila, Putatan (SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for

Not yet recruiting
  • COVID-19
  • SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • SCB-2019 (monovalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • Manila, Philippines
  • +2 more
Jun 21, 2023

COVID-19 Infection, COVID-19 Vaccine Adverse Reaction Trial in Seoul (LEM-mR203, Placebo)

Not yet recruiting
  • COVID-19 Infection
  • COVID-19 Vaccine Adverse Reaction
  • LEM-mR203
  • Placebo
  • Seoul, Korea, Republic of
    Seoul National University Hospital Clinical Trials Center
Sep 12, 2023

Ebola Virus Disease Trial in Goma, Kinshasa (Zabdeno® booster, Ervebo® booster)

Not yet recruiting
  • Ebola Virus Disease
  • Zabdeno® booster
  • Ervebo® booster
  • Goma, Congo, The Democratic Republic of the
  • +1 more
Nov 6, 2023

COVID-19, Vaccine Reaction Trial in Chengdu (LYB001, CoronaVac)

Active, not recruiting
  • COVID-19
  • Vaccine Reaction
  • LYB001
  • CoronaVac
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 29, 2023

COVID-19 Pandemic, COVID-19 Vaccines Trial in Surabaya (Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg,

Recruiting
  • COVID-19 Pandemic
  • COVID-19 Vaccines
  • Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg
  • CoronaVac Biofarma COVID-1 9 Vaccine 3 µg
  • Surabaya, East Java, Indonesia
    Dr. Soetomo General Hospital
Jun 21, 2023

Outcome of Myocarditis After COVID-19 mRNA Vaccine

Completed
  • Myocarditis
  • data collection in healthcare professionals with COVID-19 mRNA vaccine booster
  • Basel, Switzerland
    University Hospital Basel, Department of Cardiology
Jun 29, 2022